Format

Send to

Choose Destination
Clin Exp Dermatol. 2018 Aug;43(6):659-666. doi: 10.1111/ced.13552. Epub 2018 May 17.

Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes.

Author information

1
Chelsea and Westminster Hospital, London, UK.
2
Dermatological Surgery and Laser Unit, St John's Institute of Dermatology, Guy's Hospital Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK.

Abstract

Intravenous immunoglobulin (IVIg) is a solution of human IgG, salt, sugars and solvents used to treat a multitude of diseases. Although IVIg has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In part two of this review, we assess the clinical indications of IVIg in dermatological disorders and the outcomes of its use.

PMID:
29774587
DOI:
10.1111/ced.13552
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center